您要查找的是不是:
- hepatorenal tyrosinemia 肝肾型高酪氨酸血症
- Tyrosinemia with hepatorenal dysfunction 酪氨酸血症伴肝肾功能障碍
- Tyrosinemia without hepatorenal dysfunction 酪氨酸血症不伴肝肾功能障碍
- Mr.De Franchis: Hepatorenal syndrome is sort of an end stage of ascites problem. 肝肾综合症是腹水终末期的表现之一。
- ABSTRACT:Hepatorenal syndrome (HRS) is a well-recognized complication of end-stage lier disease. 摘要:肝肾综合征是一项肝病晚期普遍的并发症。
- Objective:To study the effectiveness of ascites back transfusion treating hepatorenal syndrome. 目的:研究用腹水回输方法综合治疗肝肾综合征的疗效。
- MELD score and clinical type predict prognosis in hepatorenal syndrome: releance to lier transplantation. 题目:MELD评分及临床类型预测肝肾综合症的预后:同肝移植的相关性.
- Objective study the effectiveness of ascites back transfusion treating hepatorenal syndrome. 目的研讨用腹水回输为主综合治疗肝肾综合征的疗效。
- Antifungal agents are challenged by their hepatorenal toxicity, drug resistance and single antimicrobial spectrum. 现有的抗真菌药物在发挥治疗作用的同时,存在肝肾毒性、易产生耐药性和抗菌谱单一等问题。
- Methods:The data of treatment of hepatorenal syndrome by ascites back transfusion combined with vaso-active substance was retrospectively analyzed. 方法:回顾分析我院近年来以腹水直接回输,合并应用血管活性药物治疗肝肾综合征的资料。
- Hence, early detection of impaired renal hemodynamics can contribute to the prevention and treatment of hepatorenal syndrome. 早期发现肾血流动力学的变化将有利于肝肾综合征的防治。
- Therefore, regarding original stomach, duodenal ulcer, chronic gastritis, hepatorenal hypofunction cold patient, when use must be prudent. 因此,对于原有胃、十二指肠溃疡,慢性胃炎,肝肾功能不良的感冒患者,使用时要慎重。
- Nowadays the combination of Terlipressin and albumin infusion is, I wouldn't say standard, but the preferred treatment for hepatorenal syndrome. 现在特利加压素联合白蛋白输注治疗是肝肾综合症的标准或者是有效的治疗。
- The method was used to determine free amino acids in plasma samples fromhospitals and aminoacidopathies such as hyperglycinemia,phenylketonuria,argininosuccinic acidemia,citrullinemia,homocystinuria,maple syrup urine disease and tyrosinemia were detected. 用本法在医院送检的血浆样品中检出了高甘氨酸血症、苯丙酮尿症、精氨琥珀酸血症、胍氨酸血症、同型半胱氨酸尿症、枫糖尿症和酪氨酸血症等氨基酸遗传代谢缺陷症。
- Methods retrospectively analyze the data of treatment of hepatorenal syndrome by ascites back transfusion combined with vaso-active substance. 方法回顾性分析我院近年来以腹水直接回输,合并使用血管活性药物治疗肝肾综合征的资料。
- Objective To study the changes of the serum erythropoietin(EPO) levels in patients with hepatorenal syndrome(HRS) and its clinic significance in HRS. 目的研究肝肾综合征(HRS)病人及其肾功能恢复后的血清促红细胞生成素(EPO)水平的变化,了解血清EPO水平变化在HRS中的临床意义。
- Objective To investigate the relationship between platelet activating factor (PAF) and occurrence of hepatorenal syndrome (HRS). 摘要目的:研究血小板活化因子(PAF)与肝肾综合征(HRS)的关系。
- Conclusion IVCHSD sign is a valuable CT sign in identifying the hepatic origin of huge mass located in hepatorenal recess. 结论下腔静脉肝段推移征是诊断肝肾间巨大肿块来源于肝脏的有价值的CT征象。
- Objective To evaluate IVC hepatic segment displacement (IVCHSD) sign on CT scan in determining the origin of huge mass in hepatorenal recess. 目的探讨在肝肾间巨大肿块CT定位诊断中,用下腔静脉肝段推移征象区分肝脏与非肝脏来源占位病变的价值。
- Objectives To investigate the surgical techniques, clinical experiences and therapeutic effects of simultaneous hepatorenal transplantation. 目的探讨肝肾联合移植的手术技术、治疗经验及疗效。